paclitaxel has been researched along with Carcinoma, Adenosquamous in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.78) | 18.2507 |
| 2000's | 9 (25.00) | 29.6817 |
| 2010's | 20 (55.56) | 24.3611 |
| 2020's | 6 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bazzett-Matabele, L; Bigirimana, JB; DeBoer, RJ; Katznelson, E; Nguyen, C; Nsabimana, N; Ntasumbumuyange, D; Paciorek, A; Ruhangaza, D; Shulman, LN; Shyirambere, C; Triedman, SA; Umutoni, V; Umwizerwa, A | 1 |
| Chen, J; Liu, A; Shi, B; Shi, Y | 1 |
| Artru, P; Auvray Kuentz, M; Coutzac, C; de Mestier, L; Drouillard, A; Hammel, P; Hautefeuille, V; Lecomte, T; Lièvre, A; Malka, D; Nardon, V; Pernot, S; Taieb, J; Touchefeu, Y; Tran-Minh, ML; Trouilloud, I; Turpin, A; Williet, N; Zaanan, A | 1 |
| Doolin, JW; Paredes de la Fuente, R; Peters, ML | 1 |
| Ihira, K; Kaneuchi, M; Kato, T; Kobayashi, N; Konno, Y; Mitamura, T; Murakami, G; Nozaki, A; Sakuragi, N; Shimada, C; Todo, Y; Umazume, T; Watari, H | 1 |
| Achtari, C; Herrera, FG; Levy, L; Mathevet, P; Meuwly, JY; Sarivalasis, A | 1 |
| Chen, J; Han, C; Jiao, S; Kong, W; Liu, T; Song, D; Zhang, T | 1 |
| Kang, SB; Kim, JH; Kim, KT; Kim, SM; Kim, YM; Kim, YT; Lee, JM; Lee, TS; Park, BJ | 1 |
| Hulshoff, JB; Plukker, JT; Smit, JK; van der Jagt, EJ | 1 |
| Hirano, M; Ichinose, M; Mizumoto, A; Ozamoto, Y; Takao, N; Tatsuno, M; Togawa, T; Yamamoto, Y; Yonemura, Y | 1 |
| Ding, W; Li, J; Li, Y; Wang, X | 1 |
| Aloisi, A; Angioli, R; Capriglione, S; Fiore, L; Luvero, D; Montera, R; Panici, PB; Plotti, F; Scaletta, G; Terranova, C | 1 |
| Cho, HJ; Kim, DK; Kim, HR; Kim, YH; Park, SI; Park, YS | 1 |
| Kaido, Y; Kikuchi, A; Murakami, K; Shoji, T; Sugiyama, T; Takatori, E; Takeuchi, S | 1 |
| Kataoka, K; Maeda, M; Matsubara, H; Okamura, S; Urano, F | 1 |
| Doval, DC; Kumar, JV; Rao, R; Rawal, S | 1 |
| Narahara, H; Nasu, K; Takai, N | 1 |
| Chang, TC; Chen, CK; Chou, HH; Hong, JH; Hsueh, S; Huang, YT; Lai, CH; Lee, SP; Tsai, CS; Wang, CC | 1 |
| Hosokawa, K; Kitawaki, J; Koshiba, H; Kuroboshi, H; Mori, T; Okubo, T; Sawada, M; Tatsumi, H | 1 |
| Chen, X; Hou, Y; Li, C; Li, X; Lou, G; Meng, F; Sun, M; Yin, M; Zhang, H; Zhao, F | 1 |
| Lee, DW; Lee, HN; Lee, KH; Lee, YS; Park, EK; Park, JS | 1 |
| Gottschalk, E; Koehler, C; Lanowska, M; Mangler, M; Schneider, A | 1 |
| CHEN, XD; LÜ, WG; QIN, JL; SHI, HY | 1 |
| Bai, P; Li, B; Li, HJ; Li, SM; Li, W; Wu, LY; Zhang, R | 1 |
| Enomoto, T; Fujita, M; Hamasaki, T; Hisamatsu, T; Kimura, T; Mabuchi, S; Yoshino, K | 1 |
| Belau, A; Blohmer, U; Boehmer, D; du Bois, A; Fotopoulou, C; Friese, K; Hanker, LC; Hartmann, W; Heinrich, G; Keyver-Paik, MD; Kimmig, R; Kuemmel, S; Leber, H; Lichtenegger, W; Oberhoff, C; Olbrich, C; Richter, R; Runnebaum, IB; Sehouli, J; Simon, E | 1 |
| Chang, TC; Chou, HH; Hong, JH; Huang, YT; Lai, CH; Lee, SP; Tsai, CS; Wang, CC | 1 |
| Arakawa, A; Furukawa, N; Hirashima, Y; Itani, Y; Ito, K; Murakoshi, H; Tabata, T; Takekuma, M; Takeuchi, S; Tsubamoto, H | 1 |
| Chávez-Blanco, A; Dueñas-González, A; García-López, P; González-Fierro, A; Lizano-Soberon, M; Mariscal, I; Pérez-Cárdenas, E; Segura-Pacheco, B; Taja-Chayeb, L; Trejo-Becerril, C; Treviño-Cuevas, H; Wegman-Ostrosky, T | 1 |
| Cho, MJ; Kim, JS; Kim, Ki; Kim, SY | 1 |
| Beard, M; Coia, L; Colarusso, P; Farma, J; Frucht, H; Goldberg, M; Goosenberg, E; Lampert, C; Weiner, LM | 1 |
| Edwards, RP; Gallion, HH; Kelley, JL; Kunschner, AJ; Sit, AS | 1 |
| Ciglar, S; Kukura, V; Radić, V | 1 |
| Furukawa, N; Hirashima, Y; Ito, I; Takahashi, N; Takakuwa, R; Takekuma, M; Yamada, Y; Yamamichi, G | 1 |
| Armstrong, DK; Giuntoli, RL; Gold, MA; Herzog, TJ; Lewin, S; Moore, KN; Rocconi, RP; Spannuth, WA | 1 |
| Monden, Y; Prajda, N; Taniki, T; Weber, G | 1 |
3 review(s) available for paclitaxel and Carcinoma, Adenosquamous
| Article | Year |
|---|---|
Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate; Survivin | 2015 |
A case of ovarian adenosquamous carcinoma arising from endometrioid adenocarcinoma: a case report and systematic review.
Topics: Adult; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Endometrioid; Carcinoma, Squamous Cell; Female; Gynecologic Surgical Procedures; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Survival Analysis | 2016 |
Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Brachytherapy; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Follow-Up Studies; Hematologic Diseases; Humans; Hysterectomy; Life Tables; Lymphatic Irradiation; Lymphatic Metastasis; Middle Aged; Nausea; Neoplasm Metastasis; Paclitaxel; Radiation Injuries; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Retrospective Studies; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
5 trial(s) available for paclitaxel and Carcinoma, Adenosquamous
| Article | Year |
|---|---|
A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery.
Topics: Adenocarcinoma; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Radiography; Radionuclide Imaging; Survival Rate; Uterine Cervical Neoplasms | 2015 |
Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Hysterectomy; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Proportional Hazards Models; Radiotherapy, Adjuvant; Survival Rate; Uterine Cervical Neoplasms | 2011 |
A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Paclitaxel; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2012 |
Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: a Kansai Clinical Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Paclitaxel; Uterine Cervical Neoplasms | 2012 |
Survival following intensive preoperative combined modality therapy with paclitaxel, cisplatin, 5-fluorouracil, and radiation in resectable esophageal carcinoma: a phase I report.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Preoperative Care; Survival Rate | 2003 |
28 other study(ies) available for paclitaxel and Carcinoma, Adenosquamous
| Article | Year |
|---|---|
Cervical cancer treatment in Rwanda: Resource-driven adaptations, quality indicators, and patient outcomes.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Female; Gynecology; Health Resources; Health Services Accessibility; Humans; Hysterectomy; Kaplan-Meier Estimate; Middle Aged; Neoplasm Staging; Paclitaxel; Proportional Hazards Models; Quality Indicators, Health Care; Retrospective Studies; Rwanda; Surgical Oncology; Time Factors; Time-to-Treatment; Uterine Cervical Neoplasms | 2022 |
Cost-effectiveness analysis of pembrolizumab for treatment of US patients with persistent, recurrent, or metastatic cervical cancer.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Cost-Benefit Analysis; Female; Humans; Immune Checkpoint Inhibitors; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Progression-Free Survival; Quality-Adjusted Life Years; Survival Rate; United States; Uterine Cervical Neoplasms | 2022 |
Chemotherapy in advanced pancreatic adenosquamous carcinoma: A retrospective multicenter AGEO study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Deoxycytidine; Fluorouracil; Gemcitabine; Humans; Leucovorin; Male; Paclitaxel; Pancreatic Neoplasms; Prospective Studies; Retrospective Studies | 2023 |
Partial response in non-resectable adenosquamous carcinoma of the pancreas with high tumour mutation burden treated with gemcitabine, nab-paclitaxel and pembrolizumab.
Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Deoxycytidine; Gemcitabine; Humans; Male; Mutation; Paclitaxel; Pancreas; Pancreatic Neoplasms | 2023 |
Tailored radical hysterectomy for locally advanced cervical cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organ Sparing Treatments; Paclitaxel; Peripheral Nerves; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms | 2020 |
Survival of the fetus: cervical cancer and pregnancy, a challenging combination.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Adenosquamous; Cesarean Section; Chemoradiotherapy; Cisplatin; Female; Humans; Infant, Newborn; Magnetic Resonance Imaging; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron Emission Tomography Computed Tomography; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Trimester, Second; Radiotherapy, Intensity-Modulated; Ultrasonography; Uterine Cervical Neoplasms | 2020 |
A retrospective analysis of cisplatin/carboplatin plus paclitaxel in advanced or recurrent cervical cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Retrospective Studies; Uterine Cervical Neoplasms | 2019 |
Chemoradiation with paclitaxel and carboplatin in high-risk cervical cancer patients after radical hysterectomy: a Korean Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease-Free Survival; Female; Humans; Hysterectomy; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Postoperative Care; Prospective Studies; Radiotherapy Dosage; Republic of Korea; Survival Rate; Uterine Cervical Neoplasms | 2013 |
Evaluation of progression prior to surgery after neoadjuvant chemoradiotherapy with computed tomography in esophageal cancer patients.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Disease Progression; Esophageal Neoplasms; Esophagectomy; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Preoperative Care; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2014 |
[A case of gastric adenosquamous carcinoma with peritoneal dissemination in which treatment with S-1 plus paclitaxel therapy resulted in improved long-term survival].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Drug Combinations; Gastrectomy; Humans; Male; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Stomach Neoplasms; Tegafur; Time Factors | 2014 |
Combination therapy of liposomal paclitaxel and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
Topics: Adenocarcinoma; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Female; Humans; Liposomes; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neutropenia; Paclitaxel; Peripheral Nervous System Diseases; Retrospective Studies; Treatment Outcome; Tumor Burden; Uterine Cervical Neoplasms | 2015 |
Nab-paclitaxel+gemcitabine therapy for adenosquamous carcinoma of the pancreas: an autopsy case.
Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Carcinoma, Adenosquamous; Deoxycytidine; Fatal Outcome; Gemcitabine; Humans; Male; Paclitaxel; Pancreatic Neoplasms; Tomography, X-Ray Computed | 2016 |
A retrospective study of patients with locally advanced cancer of the cervix treated with neoadjuvant chemotherapy followed by radical surgery.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Ifosfamide; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
Multimodal treatment for glassy cell carcinoma of the uterine cervix.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Combined Modality Therapy; Female; Humans; Hysterectomy; Lymph Node Excision; Paclitaxel; Radiotherapy; Uterine Cervical Neoplasms | 2009 |
Long-term outcome and prognostic factors for adenocarcinoma/adenosquamous carcinoma of cervix after definitive radiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Disease-Free Survival; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Radiation-Sensitizing Agents; Salvage Therapy; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2011 |
Neoadjuvant weekly carboplatin and paclitaxel followed by radical hysterectomy for locally advanced cervical cancer: long-term results.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Survival Rate; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2010 |
The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Time Factors; Uterine Cervical Neoplasms; Vinblastine; Young Adult | 2011 |
Pregnancy after lymphadenectomy and neoadjuvant chemotherapy followed by radical vaginal trachelectomy in FIGO stage IB1 cervical cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Cisplatin; Female; Fertility; Gynecologic Surgical Procedures; Humans; Laparoscopy; Live Birth; Lymph Node Excision; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pregnancy; Treatment Outcome; Uterine Cervical Neoplasms | 2011 |
[Histological evaluation of cervical carcinomas in FIGO stage Ib2/IIa after neoadjuvant chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Preoperative Period; Prognosis; Retrospective Studies; Uterine Cervical Neoplasms; Vincristine; Young Adult | 2011 |
[Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
Topics: Adenocarcinoma; Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Follow-Up Studies; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Remission Induction; Serpins; Uterine Cervical Neoplasms | 2011 |
Prediction of progression-free survival and response to paclitaxel plus carboplatin in patients with recurrent or advanced cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pelvic Neoplasms; Prognosis; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms | 2012 |
Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Humans; Hysterectomy; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neoplasm, Residual; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Risk; Salvage Therapy; Survival Rate; Treatment Failure; Uterine Cervical Neoplasms; Young Adult | 2012 |
Circulating nucleosomes and response to chemotherapy: an in vitro, in vivo and clinical study on cervical cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Case-Control Studies; Cisplatin; Deoxycytidine; DNA, Neoplasm; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Female; Gemcitabine; HeLa Cells; Humans; In Vitro Techniques; Mice; Mice, Nude; Middle Aged; Neoadjuvant Therapy; Neoplastic Cells, Circulating; Nucleosomes; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Prognosis; Rats; Rats, Wistar; Tumor Virus Infections; Uterine Cervical Neoplasms | 2003 |
Paclitaxel and carboplatin for recurrent or persistent cancer of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Evaluation; Female; Follow-Up Studies; Humans; Life Tables; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Peripheral Nervous System Diseases; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 2004 |
Adenosquamous carcinoma of the uterine cervix--adjuvant chemotherapeutic treatment with paclitaxel and carboplatin; a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Epirubicin; Ethanol; Fatal Outcome; Female; Gynecologic Surgical Procedures; Humans; Injections, Intralesional; Liver Neoplasms; Middle Aged; Neoplasm Staging; Paclitaxel; Sclerosing Solutions; Sclerotherapy; Treatment Outcome; Uterine Cervical Neoplasms | 2005 |
A case of glassy cell carcinoma of the uterine cervix that responded to neoadjuvant chemotherapy with paclitaxel and carboplatin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Female; Humans; Hysterectomy; Neoadjuvant Therapy; Paclitaxel; Treatment Outcome; Uterine Cervical Neoplasms | 2006 |
A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Retrospective Studies; Uterine Cervical Neoplasms | 2007 |
Synergistic action of taxol and tiazofurin in human ovarian, pancreatic and lung carcinoma cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma; Carcinoma, Adenosquamous; Cell Division; Drug Screening Assays, Antitumor; Drug Synergism; Female; Guanosine Diphosphate; Guanosine Triphosphate; Humans; Liver Neoplasms, Experimental; Lung Neoplasms; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Rats; Ribavirin; Spindle Apparatus; Tumor Cells, Cultured | 1993 |